Innovative research has revealed mutational genomic aberrations caused by Apolipoprotein B mRNA-editing catalytic polypeptide-like (APOBEC) deaminases, as being critical for myeloma initiation and progression,100 and that genomic instability is involved in the pathogenesis of myeloma.101. Here, APOB is linked to plasma cell myeloma.